Covered recipient · General Payments record
NINA Z CASEY
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,156.27
- Reported across 96 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $510.47 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $136.58 | 6 |
| ABBVIE INC. | $124.74 | 1 |
| Phathom Pharmaceuticals, Inc. | $124.74 | 1 |
| Novo Nordisk AS | $37.80 | 2 |
| Esperion Therapeutics, Inc. | $30.72 | 2 |
| Axsome Therapeutics, Inc. | $23.69 | 1 |
| HARMONY BIOSCIENCES LLC | $18.56 | 1 |
| GlaxoSmithKline, LLC. | $13.64 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $124.74 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103425409 | CMS |
| Axsome Therapeutics, Inc. | $23.69 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148309010 | CMS |
| Esperion Therapeutics, Inc. | $15.32 | 05/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129430224 | CMS |
| Esperion Therapeutics, Inc. | $15.40 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129430226 | CMS |
| GlaxoSmithKline, LLC. | $13.64 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115816537 | CMS |
| HARMONY BIOSCIENCES LLC | $18.56 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126072907 | CMS |
| Novo Nordisk Inc | $18.35 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096942631 | CMS |
| Novo Nordisk Inc | $19.45 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097151250 | CMS |
| PFIZER INC. | $6.63 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131448677 | CMS |
| PFIZER INC. | $5.43 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131433761 | CMS |
| PFIZER INC. | $3.23 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131418938 | CMS |
| PFIZER INC. | $4.50 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131403836 | CMS |
| PFIZER INC. | $3.75 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131485536 | CMS |
| PFIZER INC. | $113.04 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131445120 | CMS |
| Phathom Pharmaceuticals, Inc. | $124.74 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151046412 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.